ProcellaRX adds MH Consulting & Advisory to Ascend partner network

ProcellaRX has named MH Consulting & Advisory GmbH a strategic partner in its Ascend Ecosystem, pairing its Decision Quality Intelligence framework with AI governance expertise for regulated life sciences organizations. The move is meant to give customers more practical support as they try to implement AI in defensible, GxP-aligned ways.

Why it matters: - Regulated life sciences companies are under pressure to adopt AI without weakening quality, compliance or governance. - The new partnership aims to combine decision-making discipline with implementation guidance so organizations can build AI controls that are more defensible in regulated settings. - ProcellaRX is also using the partnership to widen access to its DQI, ForgeRX, Reinvention Lab and Quality TEA training offerings.

What happened: - ProcellaRX announced that MH Consulting & Advisory GmbH has joined the Ascend Ecosystem as a Strategic Partner. - The announcement was made July 9, 2026, from Fairfax, Virginia. - ProcellaRX built the Ascend Ecosystem to extend the reach and depth of its Decision Quality Intelligence Framework across regulated industries. - MH Consulting & Advisory is led by Martin Heitmann, who serves as Managing Director.

The details: - ProcellaRX pairs its Decision Quality Intelligence Framework with MH Consulting & Advisory's regulatory and AI governance expertise. - The partnership is intended to support regulated organizations building conscious, defensible and continuous quality decisions. - Heitmann is the lead author of the International Society for Pharmaceutical Engineering's GAMP Guide Artificial Intelligence. - Heitmann is also secretary of ISPE's Global Special Interest Group on AI. - ProcellaRX said Heitmann's work aligns with its AI qualification standard and governance annex for how organizations engineer context for AI systems. - MH Consulting & Advisory focuses on regulatory and quality strategy guidance, upskilling and enablement, and practical governance implementation for GxP-regulated organizations and suppliers. - The firm has particular depth in GAMP methodology and the use of AI in regulated areas. - ProcellaRX's partner vetting process focuses on the work itself, not only the pitch, according to Dori Gonzalez-Acevedo, Founder and CEO of ProcellaRX. - Gonzalez-Acevedo said the partnership gives customers access to contributors helping shape emerging AI governance practices. - Heitmann said ProcellaRX created a structured way to make quality decisions conscious, not incidental. - Heitmann said the Ascend Ecosystem gives both firms a shared architecture to bring GAMP-aligned AI governance guidance and hands-on implementation experience to clients. - The companies said the partnership also reflects a shared emphasis on hands-on upskilling and enablement.

Between the lines: - The announcement positions AI governance as a core operating capability, not a compliance afterthought. - ProcellaRX appears to be using Ascend to add specialist credibility around the standards and methods regulated customers will need as AI use expands. - The focus on GAMP-aligned guidance suggests the partnership is aimed squarely at industries where validation and auditability matter.

What's next: - ProcellaRX will keep expanding DQI, ForgeRX and the Reinvention Lab. - ProcellaRX also plans to build out its Quality TEA training. - MH Consulting & Advisory is expected to contribute implementation and governance expertise to clients in the Ascend network. - The companies did not disclose financial terms or a timeline for specific joint offerings.

The bottom line: - ProcellaRX is adding a governance-heavy partner to make its AI and quality framework more usable for regulated companies trying to adopt AI with confidence.